MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: February 1 2002, Volume 2, Issue 1   [Index by Author]  [Cover Caption]
       Reviews
       Speaking of Pharmacology
       Reflections
       CrossTalk
       Beyond the Bench
       Outliers
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many summaries, check the boxes to the left of the titles you want, and click the 'Get All Checked Summary(s)' button. To see one summary at a time, click its [Summary] link.

R E V I E W S:

Fulvio D'Acquisto, Michael J. May, and Sankar Ghosh
Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
Mol. Interv. 2002 2: 22-35. [Summary] [Full Text] [PDF]  

Nuclear factor {kappa}B (NF-{kappa}B) regulates the transcription of a number of proinflammatory mediators. NF-{kappa}B turns out to be an important target of traditional anti-inflammatory agents (like aspirin), and has been singled out for targeting by a new generation of drugs.

Xiao-yu R. Song, Theodore J. Torphy, Don E. Griswold, and David Shealy
Coming of Age:Anti–Cytokine Therapies
Mol. Interv. 2002 2: 36-46. [Summary] [Full Text] [PDF]  

Immune disorders that are supported by the action of cytokines are now giving way to novel therapeutics. The potential of biopharmaceuticals is transitioning into reality within the context of many diseases.

E. Costa, Y. Chen, J. Davis, E. Dong, J.S. Noh, L. Tremolizzo, M. Veldic, D.R. Grayson, and A. Guidotti
REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome
Mol. Interv. 2002 2: 47-57. [Summary] [Full Text] [PDF]  

Silencing of the Reelin gene may contribute to the etiology of schizophrenia. Investigations of Reelin and of the epigenetic mechanisms that regulate neurodevelopmental genes may provide approaches to treating psychiatric illness.

D E P A R T M E N T S:

Speaking of Pharmacology:

Barry A. Berkowitz and George Sachs
Life Cycle of A Block Buster Drug: Discovery and Development of Omeprazole (PrilosecTM)
Mol. Interv. 2002 2: 6-11. [Summary] [Full Text] [PDF]  

Reflections:

Science in the cultural context

Jennifer R. Fishman
Sex, Drugs, and Clinical Research
Mol. Interv. 2002 2: 12-16. [Full Text] [PDF]  

CrossTalk:

Interviews with people in the world of pharmacology

Science for the Common Good
Mol. Interv. 2002 2: 17-21. [Summary] [Full Text] [PDF]  

Beyond the Bench:

Representations of pharmacology and science in the media

Christine K. Carrico
The Opium (and Tobacco and Caffeine) of the Masses
Mol. Interv. 2002 2: 59. [Full Text] [PDF]  

Outliers:

Cartoon


Mol. Interv. 2002 2: 64. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many summaries, check the boxes to the left of the titles you want, and click the 'Get All Checked Summary(s)' button. To see one summary at a time, click its [Summary] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.